Health Bidding War Intensifies for Metsera’s PD-(L)1xVEGF Bispecific Drug The competitive landscape for the PD-(L)1xVEGF bispecific drug has intensified as several pharmaceutical companies engage in a heated bidding war for Metsera. This development... Editorial3 hours ago